SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, Bronwen E. Lambson, Túlio de Oliveira, Marion Vermeulen, Karin van den Berg, Theresa M. Rossouw, Michael T. Boswell, Veronica Ueckermann, Susan Meiring, Anne von Gottberg, Cheryl Cohen, Lynn Morris, Jinal N. Bhiman, Penny L. Moore
Topics & Concepts
NeutralizationConvalescent plasmaSpike ProteinVirologyMonoclonal antibodyAntibodyLineage (genetic)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Recombinant DNACoronavirusBiologySpike (software development)2019-20 coronavirus outbreakGeneGeneticsMedicineEconomicsPathologyInfectious disease (medical specialty)DiseaseManagementOutbreakSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing